Similar articles

• Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.

  Gammon WR, Merritt CC, Lewis DM, Sams WM Jr, Wheeler CE Jr, Carlo JR. Gammon WR, et al. J Invest Dermatol. 1982 Jan;78(1):52-7. doi: 10.1111/1523-1747.ep12497912. J Invest Dermatol. 1982. PMID: 7033396
• The immunopathology of bullous pemphigoid.

  Imber MJ, Murphy GF, Jordon RE. Imber MJ, et al. Clin Dermatol. 1987 Jan-Mar;5(1):81-92. doi: 10.1016/0738-081x(87)90053-8. Clin Dermatol. 1987. PMID: 3552196 Review. No abstract available.
• Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method.

  Gammon WR, Merritt CC, Lewis DM, Sams WM Jr, Wheeler CE Jr, Carlo J. Gammon WR, et al. J Invest Dermatol. 1981 Jun;76(6):514-22. doi: 10.1111/1523-1747.ep12521246. J Invest Dermatol. 1981. PMID: 7017015 No abstract available.
• Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.

  Anhalt GJ, Patel H, Diaz LA. Anhalt GJ, et al. Arch Dermatol. 1983 Sep;119(9):711-4. Arch Dermatol. 1983. PMID: 6351756 Review. No abstract available.
• Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.

  Brooks WS, Lee YY, Abell E, Deng JS. Brooks WS, et al. J Clin Lab Anal. 1989;3(5):307-11. doi: 10.1002/jcla.1860030509. J Clin Lab Anal. 1989. PMID: 2681622